AU2014904075A0 - Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof - Google Patents

Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof

Info

Publication number
AU2014904075A0
AU2014904075A0 AU2014904075A AU2014904075A AU2014904075A0 AU 2014904075 A0 AU2014904075 A0 AU 2014904075A0 AU 2014904075 A AU2014904075 A AU 2014904075A AU 2014904075 A AU2014904075 A AU 2014904075A AU 2014904075 A0 AU2014904075 A0 AU 2014904075A0
Authority
AU
Australia
Prior art keywords
haloallylamine
sulfone derivative
lysyl oxidases
derivative inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014904075A
Inventor
Mandar Deodhar
Alison Dorothy Findlay
Jonathan Stuart Foot
Wolfgang JAROLIMEK
Alan Duncan Robertson
Craig Ivan Turner
Wenbin ZHOU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaxis Ltd
Original Assignee
Pharmaxis Ltd
Filing date
Publication date
Application filed by Pharmaxis Ltd filed Critical Pharmaxis Ltd
Publication of AU2014904075A0 publication Critical patent/AU2014904075A0/en
Abandoned legal-status Critical Current

Links

AU2014904075A 2014-10-13 Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof Abandoned AU2014904075A0 (en)

Publications (1)

Publication Number Publication Date
AU2014904075A0 true AU2014904075A0 (en) 2014-10-30

Family

ID=

Similar Documents

Publication Publication Date Title
EP3541932A4 (en) Inhibitors of crispr-cas9
EP3429591A4 (en) Substituted inhibitors of menin-mll and methods of use
AU2015342774B2 (en) EZH2 inhibitors and uses thereof
EP3377612A4 (en) Functional expression of monooxygenases and methods of use
EP3125884A4 (en) Small molecule inhibitors of mcl-1 and uses thereof
EP3510040A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3344039A4 (en) Small molecule inhibitors of dyrk1a and uses thereof
EP3110820A4 (en) Tyk2 inhibitors and uses thereof
EP3558998A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3445365A4 (en) Ezh2 inhibitors and uses thereof
EP3435956A4 (en) Photo-stabilized compositions and methods of use
EP3288553A4 (en) Combinations of cannabinoids and n-acylethanolamines
EP3210992A4 (en) New type of cytidine derivative and application thereof
EP3177327A4 (en) Inhibitors of myh7b and uses thereof
EP3226955A4 (en) Self-anchoring catheters and methods of use
EP3190886A4 (en) Compositions and methods of use thereof
EP3110415A4 (en) Compositions and methods for inhibition of mycobacteria
EP3376862A4 (en) Cryopreservative compositions and methods of use thereof
EP3124466A4 (en) Triarylamine derivative and use of same
EP3180335A4 (en) Cytochrome p450 inhibitors and uses thereof
EP3207029A4 (en) Tryptamide compositions and methods of use
EP3528892A4 (en) Antioxidant-enriched multivitamin composition and methods of use
EP3285583A4 (en) Small molecule inhibitors of mcl-1 and uses thereof
AU2014904075A0 (en) Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof